About
Company Strategy
Group Structure
Board of directors
Management
Career
Contacts
Development
Drugs
Medical devices
Medical services
Biotech valuation
Activity
Areas of activities
Research and development (R&D) stages
Ecosystem
Acceleration
Commercialization
Investor
Disclosure of information
News
En
RU
CN
Главная
News
News
News, press releases, events, publications
All categories
All categories
News
Press releases
Press about us
Portfolio
Portfolio
Genetico
Gemabank
Histograft
Nextgen
Genotarget
Biotechnology Developments
Betuvax
Reprobank
Vitacel
13.04.2023
Press releases
RBT begins researching a new immunomodulatory drug
11.04.2023
Press releases
Genetico approved the IPO parameters
10.04.2023
News
RBT investors received an offer
06.04.2023
News
Skolkovo to reimburse business angels for up to 50% of their investments in vaccine development
29.03.2023
News
Genetico to hold an IPO on the Moscow Exchange
27.03.2023
News
ACRA confirmed the BB+(RU) credit rating of HSCI
24.03.2023
News
RBT raises funds on the Rounds platform
1
…
10
11
12
13
14
Up
About the Company
About
Company Strategy
Group Structure
Board of Directors
Management
Career
Contacts
Development Portfolio
Drugs
Medical Devices
Medical Services
Activity
Areas of activities
Research and development (R&D) stages
Ecosystem
Acceleration
Commercialization
Biotech Valuation
Investors
Disclosure of information
